跳至主要内容
临床试验/NCT02576002
NCT02576002已完成不适用

Study to Estimate the Incidence and Prevalence and Treatment Patterns of Pediatric Pulmonary Hypertension in the US

Bayer0 个研究点目标入组 2,691 人开始时间: 2015年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Bayer
入组人数
2,691
主要终点
Incidence rate of PAH (pulmonary arterial hypertension)

研究概览

简要总结

To describe the prevalence, incidence and current treatment and procedures patterns in a US pediatric population with PAH in MarketScan database during the period 2010-2013

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • All PAH patients who were in the MarketScan database and who were under age 18 at some time during the years 2010 through 2013

排除标准

  • Not applicable

研究组 & 干预措施

Pediatric PAH patients

US pediatric population with PAH in MarketScan database during the period 2010-2013

干预措施: Assigned pulmonary hypertension medication (Drug)

结局指标

主要结局

Incidence rate of PAH (pulmonary arterial hypertension)

时间窗: Retrospective analysis of three year period

Prevalence rate of PAH

时间窗: Retrospective analysis of three year period

次要结局

  • Assigned drug treatment for PAH measured using the MarketScan database(Retrospective analysis of three year period)
  • Diagnostic procedures performed among PAH patients measured using the MarketScan database(Retrospective analysis of three year period)
  • Prevalence of comorbidities among PAH patients(Retrospective analysis of three year period)

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

相似试验

Epidemiology and Treatment Patterns of Paediatric... | 临床试验